Association of Selinexor Dose Reductions With Clinical Outcomes in the BOSTON Study
Article 2023 en
Authors
SJ
Sundar Jagannath
SD
Sosana Delimpasi
SG
Sebastian Grosicki
Abstract
1 min read
Appropriate dose reductions in response to AEs of the 100 mg selinexor starting dose in the BOSTON study were associated with improved efficacy, reduced AE rates and improved QoL.
María‐Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella, Holger W. Auner, Michèle Cavo, Meletios A Dimopoulos, Martina Bianco, G Merlo, Charles la Porte, Philippe Moreau
María‐Victoria Mateos, Maria Gavriatopoulou, Thierry Façon, Holger W. Auner, Xavier Leleu, Roman Hájek, Meletios A Dimopoulos, Sosana Delimpasi, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryna Kriachok, Halyna Pylypenko, Vadim Doronin, Ganna Usenko, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath, Philippe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson, Nizar J. Bahlis, Michèle Cavo, Yi Chai, Jacqueline Jeha, Melina Arazy, Jatin J. Shah,
Emanuela Palmerini, S. Veltkamp, H. Gelderblom, Javier Martín‐Broto, A. Sebio García, M. Van de Sande, Gabriel Tinoco, Elyse Seltzer, Matthew Davies, Jean Yves Blay
Vânia T. M. Hungria, Katja Weisel, Atanas Radinoff, Sosana Delimpasi, Gábor Mikala, Tamás Masszi, Li J, Marcelo Capra, Ângelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Löw, Morio Matsumoto, Mary Li, Neal Sule, Margaret Polinkovsky, Randy Davis, Shelley Bright, Astrid McKeown, Joanna Opalińska, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.